MFGE8 and hypertensive disorder: Recently, not only has MFG-E8 expression emerged as a molecular hallmark of adverse cardiovascular remodeling with age41–44, but MFG-E8 signaling has also been found to mediate the vascular outcomes of cellular and matrix responses to the hostile stresses associated with hypertension, diabetes, and atherosclerosis45–49.